Status:
UNKNOWN
Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma
Lead Sponsor:
Sun Yat-sen University
Conditions:
Natural Killer T-cell Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the Predictive value of a SNP signature and liquid biopsy in patients with natural killer T-cell lymphoma.
Eligibility Criteria
Inclusion
- biopsy proved Natural Killer T-cell Lymphoma
- newly diagnosed patients
Exclusion
- patients with biopsy samples unavailable
Key Trial Info
Start Date :
March 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04423536
Start Date
March 9 2021
End Date
March 1 2025
Last Update
May 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University,
Guangzhou, China, 51000